Solifenacin

🧮 Dose calculator

Overactive bladder · Regimen source: FDA Solifenacin · 2.1FDA Solifenacin · 2

• • CrCl <30: max 5 mg. FDA Solifenacin · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Solifenacin · 8.1

  “Risk Summary There are no studies with the use of solifenacin succinate in pregnant women to inform a drug-associated risk of major birth defects, miscarriages, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Solifenacin · 8.2

  “Risk Summary There is no information on the presence of solifenacin in human milk, the effects on the breastfed child, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Solifenacin · 8.4

  “The safety and effectiveness of solifenacin succinate tablets have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Solifenacin · 8.5

  “In placebo-controlled clinical studies, similar safety and effectiveness were observed between geriatric patients (623 patients ≥ 65 years and 189 patients ≥ 75 years) and younger adult patients (1188 patients < 65 years) treated with solifenacin succinate tablets.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.